Controlled Substance E-Prescribing Now Permitted Nationally
Meghan Ross, Associate Editor
All US states now permit electronic prescribing of controlled substances, with Missouri’s recent formal authorization making it the final state to do so.
Krystle Vermes
A generic equivalent to Bristol-Myers Squibb’s entecavir (Baraclude) hepatitis B treatment has been approved by the FDA.
Jeannette Y. Wick, RPh, MBA, FASCP
In the recent past, bipolar disorder has been classified as the most costly mental illness.
Meghan Ross, Associate Editor
A list of the most debilitating diseases a patient may face over his or her lifetime was recently curated by Healthcare Business and Technology.
Meghan Ross, Associate Editor
The FDA has proposed adding a 4-letter suffix to the names of biosimilars to distinguish them from their biologic counterparts.
Jeannette Y. Wick, RPh, MBA, FASCP
Multidose medication dispensing at discharge (MMDD) involves supplying products that have been partially used during hospitalization to ensure continuity of care.
Allison Gilchrist, Associate Editor
The 340B Program “mega-guidance” just released by the Health Resources and Services Administration (HRSA) clarifies how patients can receive deeply discounted drugs.
Krystle Vermes
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes may cause severe and disabling joint pain, the FDA has warned.

Association News

The National Association of Chain Drug Stores today announced the winners of the 2015 NACDS Total Store Expo Product Showcase.
National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey, RPh, MBA issued a statement in response to the J.D. Power 2015 U.S. Pharmacy StudySM released today.
NACDS today bestowed pharmacy’s highest honor – the Harold W. Pratt Award – to industry leader Robert Thompson during today’s business program at the 2015 NACDS Total Store Expo.
In conjunction with IMS Health, the NACDS Foundation recognized two industry leaders with the IMS Health Bernie Greenberg Pharmacy Partnership Award.

Pharmacy Market News

Valeant Pharmaceuticals has announced that it has entered into a definitive agreement under which it will acquire Mercury (Cayman) Holdings, the holding company of Amoun Pharmaceutical
Celgene Corporation today announced it has closed its acquisition of Receptos, Inc.
Novo Nordisk today announced that it has entered into a definitive agreement under which Novo Nordisk will acquire Calibrium LLC and MB2 LLC, two privately held biopharmaceutical research companies based in Indiana, US.

Strategic Alliance Partner News

CVS Health has entered into new clinical affiliations with St. Luke’s University Health Network in Bethlehem, Pennsylvania, and TriHealth in Cincinnati, Ohio.
Walgreens and Providence Health & Services have announced a strategic clinical collaboration aimed at coordinating patient care and improving patient access, which plans to bring up to 25 new retail clinics to Oregon and Washington.
Latest Issues